(Circulation. 2001;104:670.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Departments of Medicine (A.R.M., D.B.), Surgery (A.B., Y.N., N.J., M.D., M.C.O.), and Biomedical Engineering (J.W.H.), Columbia University, New York City, NY; and the Department of Anesthesiology and Critical Care Medicine (P.M.H., A.H.S.T.), Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY.
Correspondence to Daniel Burkhoff, MD, PhD, Columbia University, Black Bldg 812, 650 W 168th St, New York City, NY 10032. E-mail db59{at}columbia.edu
Background Left ventricular assist devices (LVAD) reverse ventricular, myocardial, and systemic abnormalities characteristic of severe heart failure (reverse remodeling). The relative contributions of hemodynamic unloading and normalized biochemical milieu to reverse remodeling are unknown.
Methods and Results Structural and functional characteristics were measured from 53 hearts of patients undergoing transplantation without LVAD support (medical support) and 33 hearts from patients receiving a median of 46 days of LVAD support (range, 8 to 360 days). Compared with medical support alone, patients receiving LVAD support for
30 days had higher central venous pressures (11±6 versus 8±5 mm Hg, P=0.04), lower pulmonary artery diastolic pressures (14±9 versus 21±9 mm Hg, P=0.01), and higher cardiac outputs (5.1±1.6 versus 3.7±1.0 L/min, P<0.001). In LVAD versus transplantation hearts, V30 (ex vivo volume yielding ventricular pressure of 30 mm Hg) was decreased in the left ventricle (LV) (179±75 versus 261±118 mL, P=0.005) but not in the right ventricle (RV) (140±59 versus 148±52 mL, P=NS). LV myocyte diameter decreased more significantly after LVAD support (17%, P=0.05) than in the RV (11%, P=NS). Compared with transplantation, LVAD support increased normalized SERCA2a content in the LV (0.51±0.26 versus 1.04±0.34, P<0.001) but not in the RV (0.48±34 versus 0.67±0.55, P=NS). Finally, LVAD support improved force-frequency relations of isolated superfused LV trabeculae (P=0.01) but not RV trabeculae.
Conclusions Reduction of hemodynamic load is a primary factor underlying several important features of reverse remodeling. These findings do not preclude a possible primary role of neurohormonal factors underlying other facets of reverse remodeling during LVAD support.
Key Words: mechanics remodeling hemodynamics
This article has been cited by other articles:
![]() |
H. Brinks, H. Tevaearai, C. Muhlfeld, D. Bertschi, B. Gahl, T. Carrel, and M.-N. Giraud Contractile function is preserved in unloaded hearts despite atrophic remodeling. J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 742 - 746. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, A. Marui, T. Ikeda, and M. Komeda Partial left ventricular unloading reverses contractile dysfunction and helps recover gene expressions in failing rat hearts Interactive CardioVascular and Thoracic Surgery, February 1, 2008; 7(1): 27 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Perrino, J. N. Schroder, B. Lima, N. Villamizar, J. J. Nienaber, C. A. Milano, and S. V. Naga Prasad Dynamic Regulation of Phosphoinositide 3-Kinase-{gamma} Activity and -Adrenergic Receptor Trafficking in End-Stage Human Heart Failure Circulation, November 27, 2007; 116(22): 2571 - 2579. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maybaum, D. Mancini, S. Xydas, R. C. Starling, K. Aaronson, F. D. Pagani, L. W. Miller, K. Margulies, S. McRee, O.H. Frazier, et al. Cardiac Improvement During Mechanical Circulatory Support: A Prospective Multicenter Study of the LVAD Working Group Circulation, May 15, 2007; 115(19): 2497 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Suzuki, T.-S. Li, A. Mikamo, M. Takahashi, M. Ohshima, M. Kubo, H. Ito, and K. Hamano The reduction of hemodynamic loading assists self-regeneration of the injured heart by increasing cell proliferation, inhibiting cell apoptosis, and inducing stem-cell recruitment J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1051 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Hauptman and H. N. Sabbah Reversal of ventricular remodeling: Important to establish and difficult to define Eur J Heart Fail, April 1, 2007; 9(4): 325 - 328. [Full Text] [PDF] |
||||
![]() |
S. Klotz, A.H. J. Danser, R. F. Foronjy, M. C. Oz, J. Wang, D. Mancini, J. D'Armiento, and D. Burkhoff The Impact of Angiotensin-Converting Enzyme Inhibitor Therapy on the Extracellular Collagen Matrix During Left Ventricular Assist Device Support in Patients With End-Stage Heart Failure J. Am. Coll. Cardiol., March 20, 2007; 49(11): 1166 - 1174. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Brower, J. D. Gardner, M. F. Forman, D. B. Murray, T. Voloshenyuk, S. P. Levick, and J. S. Janicki The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 604 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deb, J. Yun, N. Burton, E. Omron, J. Thurber, and S. D. Nathan Reversal of idiopathic pulmonary arterial hypertension and allograft pneumonectomy after single lung transplantation. Chest, July 1, 2006; 130(1): 214 - 217. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kogler, P. Schott, K. Toischer, H. Milting, P. N. Van, M. Kohlhaas, C. Grebe, A. Kassner, E. Domeier, N. Teucher, et al. Relevance of Brain Natriuretic Peptide in Preload-Dependent Regulation of Cardiac Sarcoplasmic Reticulum Ca2+ ATPase Expression Circulation, June 13, 2006; 113(23): 2724 - 2732. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Heerdt, S. Klotz, and D. Burkhoff Cardiomyopathic Etiology and SERCA2a Reverse Remodeling During Mechanical Support of the Failing Human Heart Anesth. Analg., January 1, 2006; 102(1): 32 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wohlschlaeger, K. J. Schmitz, C. Schmid, K. W. Schmid, P. Keul, A. Takeda, S. Weis, B. Levkau, and H. A. Baba Reverse remodeling following insertion of left ventricular assist devices (LVAD): A review of the morphological and molecular changes Cardiovasc Res, December 1, 2005; 68(3): 376 - 386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Simon, R. L. Kormos, S. Murali, P. Nair, M. Heffernan, J. Gorcsan, S. Winowich, and D. M. McNamara Myocardial Recovery Using Ventricular Assist Devices: Prevalence, Clinical Characteristics, and Outcomes Circulation, August 30, 2005; 112(9_suppl): I-32 - I-36. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mancini and D. Burkhoff Mechanical Device-Based Methods of Managing and Treating Heart Failure Circulation, July 19, 2005; 112(3): 438 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Klotz, R. F. Foronjy, M. L. Dickstein, A. Gu, I. M. Garrelds, A.H. Jan Danser, M. C. Oz, J. D'Armiento, and D. Burkhoff Mechanical Unloading During Left Ventricular Assist Device Support Increases Left Ventricular Collagen Cross-Linking and Myocardial Stiffness Circulation, July 19, 2005; 112(3): 364 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Burkhoff and S. A. Ben-Haim Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2550 - H2556. [Full Text] [PDF] |
||||
![]() |
S. Klotz, A. Barbone, S. Reiken, J. W. Holmes, Y. Naka, M. C. Oz, A. R. Marks, and D. Burkhoff Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties J. Am. Coll. Cardiol., March 1, 2005; 45(5): 668 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Chaudhary, E. I. Rossman, V. Piacentino III, A. Kenessey, C. Weber, J. P. Gaughan, K. Ojamaa, I. Klein, D. M. Bers, S. R. Houser, et al. Altered myocardial Ca2+ cycling after left ventricular assist device support in the failing human heart J. Am. Coll. Cardiol., August 18, 2004; 44(4): 837 - 845. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vlasblom, A. Muller, R. J.P Musters, M. J Zuidwijk, C. van Hardeveld, W. J Paulus, and W. S Simonides Contractile arrest reveals calcium-dependent stimulation of SERCA2a mRNA expression in cultured ventricular cardiomyocytes Cardiovasc Res, August 15, 2004; 63(3): 537 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pieske Reverse remodeling in heart failure - fact or fiction? Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D66 - D78. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Messe, I. E. Silverman, J. R. Kizer, S. Homma, C. Zahn, G. Gronseth, and S. E. Kasner Practice Parameter: Recurrent stroke with patent foramen ovale and atrial septal aneurysm: Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, April 13, 2004; 62(7): 1042 - 1050. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. P. Uray, J. H. Connelly, O.H. Frazier, H. Taegtmeyer, and P. J.A. Davies Mechanical unloading increases caveolin expression in the failing human heart Cardiovasc Res, July 1, 2003; 59(1): 57 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. F. Hon and M. H. Yacoub Bridge to recovery with the use of left ventricular assist device and clenbuterol Ann. Thorac. Surg., June 1, 2003; 75(90060): S36 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. McGowan, C. B. Scott, A. Mu, R. J. McCormick, D. P. Thomas, and K. B. Margulies Unloading-induced remodeling in the normal and hypertrophic left ventricle Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2061 - H2068. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Reiken, X. H.T. Wehrens, J. A. Vest, A. Barbone, S. Klotz, D. Mancini, D. Burkhoff, and A. R. Marks {beta}-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure Circulation, May 20, 2003; 107(19): 2459 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S Chugh, S. Whitesel, M. Turner, C. T Roberts Jr., and S. R Nagalla Genetic basis for chamber-specific ventricular phenotypes in the rat infarct model Cardiovasc Res, February 1, 2003; 57(2): 477 - 485. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Saavedra, R. S. Tunin, N. Paolocci, T. Mishima, G. Suzuki, C. W. Emala, P. A. Chaudhry, P. Anagnostopoulos, R. C. Gupta, H. N. Sabbah, et al. Reverse remodeling and enhancedadrenergic reserve from passive externalsupport in experimental dilated heart failure J. Am. Coll. Cardiol., June 19, 2002; 39(12): 2069 - 2076. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Heerdt, M. Schlame, R. Jehle, A. Barbone, D. Burkhoff, and T. J.J. Blanck Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device Ann. Thorac. Surg., April 1, 2002; 73(4): 1216 - 1221. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. de Jonge, D. F. van Wichen, M. E. I. Schipper, J. R. Lahpor, F. H. J. Gmelig-Meyling, E. O. Robles de Medina, and R. A. de Weger Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading: An immunohistochemical analysis of the contractile myofilaments J. Am. Coll. Cardiol., March 20, 2002; 39(6): 963 - 969. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |